欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0860/001
药品名称Aminomix peripheral solution for infusion
活性成分
    • Alanine 4.9 g
    • Arginine 4.2 g
    • Calcium chloride dihydrate 0.24 g
    • Glycine 3.85 g
    • Histidine 1.05 g
    • Isoleucine 1.75 g
    • Leucine 2.59 g
    • Lysine acetate 3.26 g
    • magnesium sulfate heptahydrate 0.78 g
    • Methionine 1.51 g
    • Phenylalanine 1.79 g
    • Potassium chloride 1.41 g
    • Proline 3.92 g
    • Serine 2.28 g
    • Sodium acetate 0.7 g
    • SODIUM GLYCEROPHOSPHATE 1.78 g
    • Taurine 0.35 g
    • Threonine 1.54 g
    • Tryptophan 0.7 g
    • Tyrosine 0.14 g
    • Valine 2.17 g
剂型Solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstraße 36 AT-8055 Graz
参考成员国 - 产品名称Austria (AT)
Aminomix peripheral Infusionslösung
互认成员国 - 产品名称
    • Germany (DE)
      Aminomix peripher,Infusionslösung
    • Italy (IT)
    • Sweden (SE)
    • Czechia (CZ)
      Aminomix Peripheral
    • Slovakia (SK)
      Aminomix Peripheral
许可日期2020/03/05
最近更新日期2025/09/10
药物ATC编码
    • B05BA Solutions for parenteral nutrition
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase